Skip to content

Zero Fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for Right Atrial Arrhythmias

Multi-center, Randomized, Controlled Trial to Compare Feasibility, Safety and Efficacy of Zero-Fluoroscopic Navigation With Conventional Fluoroscopic Navigation for the Ablation of Right Atrial Arrhythmias

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03151278
Acronym
ZFA-RAA
Enrollment
212
Registered
2017-05-12
Start date
2011-01-31
Completion date
2018-12-31
Last updated
2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Arrhythmia, Atrial Premature Complexes, Atrial Tachycardia

Keywords

Fluoroscopy, Ablation, Three dimensional, Atrial arrhythmia, Radiation

Brief summary

This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach with conventional fluoroscopic approach as performing catheter ablation of right atrial arrhythmias.

Detailed description

Catheter ablation is a well-established treatment to treat patients with a wide range of heart rhythm disturbances. Fluoroscopy is the imaging modality routinely used for cardiac device implantation and electrophysiological procedures. Due to the rising concern regarding the harmful effects of radiation exposure to both the patients and operation staffs, novel three-dimensional mapping systems such as Ensite NavX have been developed and implemented in electrophysiological procedure for the navigation of catheters inside the heart chambers. Ensite NavX is a promising system to guide catheters inside the cardiac chambers and vessels without the use of fluoroscopy. This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach with conventional fluoroscopic approach as performing catheter ablation of right atrial arrhythmias.

Interventions

Catheter ablation will be performed under the guidance of one kind of three-dimensional navigation system and without fluoroscopic guidance.

Catheter ablation will be performed using fluoroscopy plus one kind of three-dimensional navigation system.

Sponsors

Fu Wai Hospital, Beijing, China
CollaboratorOTHER
Xinyang Central Hospital
CollaboratorOTHER
Ningbo No. 1 Hospital
CollaboratorOTHER
Shanghai Tongji Hospital, Tongji University School of Medicine
CollaboratorOTHER
First Affiliated Hospital of Guangxi Medical University
CollaboratorOTHER
Shenzhen Sun Yat-sen Cardiovascular Hospital
CollaboratorOTHER
Guangdong Provincial People's Hospital
CollaboratorOTHER
Zhongshan Hospital Xiamen University
CollaboratorOTHER
Tongji Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Atrial Tachycardia * Atrial Premature Complexes

Exclusion criteria

* Left Atrial Premature Complexes * Left Atrial Tachycardia

Design outcomes

Primary

MeasureTime frameDescription
Total success rates3 monthsThe patients have no related arrhythias or recurrence during follow up.

Secondary

MeasureTime frameDescription
Complications6 monthsThe patients have no related complications during follow up.
Immediate success rate24 hoursElectrophysiologic study shows success of ablation
Total procedure timeduring procedureThe patients have no related arrhythias or recurrence during follow up.
Fluoroscopy timeduring procedureFrom skin puncture to withdrawal of all the catheters.
Recurrence rate6 monthsThe patients have no related arrhythias or recurrence during follow up.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026